Comparison of drug-eluting balloon versus drug-eluting stent in patients with in-stent restenosis: Insight from randomized controlled trials

International Journal of Cardiology

Volumn 179, Issue , 2015, Pages 424-429

  Mamuti, Wahafu ^a   Ablimit, Alimjan ^a   Kelimu, Wumaierjiang ^a   Rao, Fang ^a   Jiamali, Abulimiti ^a   Zhang, Wei ^a   Pei, Xiaoli ^a   Zhang, Feng ^b  

^a Kashgar First People's Hospital of Xinjiang   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Coronary artery disease; Drug eluting balloon; Drug eluting stent; In stent restenosis

Indexed keywords

ADVERSE OUTCOME; CARDIOVASCULAR EQUIPMENT; COMPARATIVE EFFECTIVENESS; DEVICE SAFETY; DRUG ELUTING BALLOON; DRUG ELUTING STENT; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; COMPARATIVE STUDY; CORONARY RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84920652357     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.11.114     Document Type: Article

References (29)

1. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, and R. Mehran In-stent restenosis in the drug-eluting stent era J. Am. Coll. Cardiol. 56 23 2010 1897 1907
2. A. Kastrati, J. Mehilli, and N. von Beckerath Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2 2005 165 171
3. F. Alfonso, M.J. Pérez-Vizcayno, and R. Hernandez A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial J. Am. Coll. Cardiol. 47 2006 2152 2160
4. G.W. Stone, S.G. Ellis, and C.D. O'Shaughnessy Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial JAMA 295 11 2006 1253 1263
5. A. Dibra, A. Kastrati, and F. Alfonso Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials J. Am. Coll. Cardiol. 49 5 2007 616 623
6. S. Habara, K. Mitsudo, and K. Kadota Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis JACC Cardiovasc. Interv. 4 2 2011 149 154
7. B. Scheller, Y.P. Clever, and B. Kelsch Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter JACC Cardiovasc. Interv. 5 3 2012 323 330
8. H. Rittger, J. Brachmann, and A.M. Sinha A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J. Am. Coll. Cardiol. 59 15 2012 1377 1382
9. S. Habara, M. Iwabuchi, and N. Inoue A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis Am. Heart J. 166 3 2013 527 533
10. M. Unverdorben, C. Vallbracht, and B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 23 2009 2986 2994
11. F. Alfonso, M.J. Pérez-Vizcayno, and A. Cárdenas A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent in-stent restenosis: the RIBS V clinical trial J. Am. Coll. Cardiol. 63 14 2014 1378 1386
12. R.A. Byrne, F.J. Neumann, and J. Mehilli Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 9865 2013 461 467
13. B. Xu, R. Gao, and J. Wang A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial JACC Cardiovasc. Interv. 7 2 2014 204 211
14. M. Egger, S. Ebrahim, and G.D. Smith Where now for meta-analysis? Int. J. Epidemiol. 31 2002 1 5
15. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J. Natl. Cancer Inst. 22 1959 719 748
16. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control. Clin. Trials 7 1986 177 188
17. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
18. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
19. S. Sharma, N. Kukreja, C. Christopoulos, and D.A. Gorog Drug-eluting balloon: new tool in the box Expert Rev. Med. Devices 7 3 2010 381 388
20. A. De Labriolle, R. Pakala, L. Bonello, G. Lemesle, M. Scheinowitz, and R. Waksman Paclitaxel-eluting balloon: from bench to bed Catheter. Cardiovasc. Interv. 73 5 2009 643 652
21. E. Stabile, V. Virga, and L. Salemme Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis J. Am. Coll. Cardiol. 60 18 2012 1739 1742
22. F. Liistro, I. Porto, and P. Angioli Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia Circulation 128 6 2013 615 621
23. M. Fusaro, S. Cassese, and G. Ndrepepa Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison Int. J. Cardiol. 168 4 2013 4002 4009
24. F. Liistro, S. Grotti, and I. Porto Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery) JACC Cardiovasc. Interv. 6 12 2013 1295 1302
25. R. Gandini, C. Del Giudice, S. Merolla, D. Morosetti, E. Pampana, and G. Simonetti Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study J. Endovasc. Ther. 20 6 2013 805 814
26. D. Scheinert, S. Duda, and T. Zeller The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty JACC Cardiovasc. Interv. 7 1 2014 10 19
27. F. Fanelli, A. Cannavale, M. Corona, P. Lucatelli, A. Wlderk, and F.M. Salvatori The "DEBELLUM" - lower limb multilevel treatment with drug eluting balloon - randomized trial: 1-year results J. Cardiovasc. Surg. (Torino) 55 2 2014 207 216
28. A. Latib, A. Colombo, and F. Castriota A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study J. Am. Coll. Cardiol. 60 24 2012 2473 2480
29. M. Unverdorben, F.X. Kleber, and H. Heuer Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months? EuroIntervention 9 5 2013 620 628